Risk of cancer in relatives of patients with myotonic dystrophy: a population‐based cohort study

Abstract

The present study does not support an increased risk of cancer in non-DM relatives of DM patients suggesting that cancer and DM are associated through derived effects of the DM genotype.

Survival patterns and cancer determinants in families with myotonic dystrophy type 1

“…However, the association in our study was seen only in parents and was not in siblings or offspring. A previous large population-based study of cancer risk in family members of DM1 patients suggested that cancer risk in DM families (disease subtype was not available) was driven by individuals’ DM status [31].…”

Neurology in evolution 2014–2015

“…Inflammatory neuropathies have likewise been amenable to treatment but still recognised to cause significant morbidity [184][185][186][187][188][189][190]. Myotonic dystrophy is a channelopathy with CNS as well as myopathic involvement and in common with other disorders of this class has overlap with neurodegenerative diseases [191][192][193][194]. The inflammatory neuropathies in some cases form an overlap with CNS infections [195][196][197][198][199][200][201].…”